Your browser doesn't support javascript.
loading
Larger putamen in individuals at risk and with manifest bipolar disorder.
Thomas-Odenthal, Florian; Stein, Frederike; Vogelbacher, Christoph; Alexander, Nina; Bechdolf, Andreas; Bermpohl, Felix; Bröckel, Kyra; Brosch, Katharina; Correll, Christoph U; Evermann, Ulrika; Falkenberg, Irina; Fallgatter, Andreas; Flinkenflügel, Kira; Grotegerd, Dominik; Hahn, Tim; Hautzinger, Martin; Jansen, Andreas; Juckel, Georg; Krug, Axel; Lambert, Martin; Leicht, Gregor; Leopold, Karolina; Meinert, Susanne; Mikolas, Pavol; Mulert, Christoph; Nenadic, Igor; Pfarr, Julia-Katharina; Reif, Andreas; Ringwald, Kai; Ritter, Philipp; Stamm, Thomas; Straube, Benjamin; Teutenberg, Lea; Thiel, Katharina; Usemann, Paula; Winter, Alexandra; Wroblewski, Adrian; Dannlowski, Udo; Bauer, Michael; Pfennig, Andrea; Kircher, Tilo.
Afiliación
  • Thomas-Odenthal F; Department of Psychiatry and Psychotherapy, Philipps-Universität Marburg, Marburg, Germany.
  • Stein F; Center for Mind, Brain and Behavior (CMBB), Universities of Marburg and Gießen, Marburg, Germany.
  • Vogelbacher C; Department of Psychiatry and Psychotherapy, Philipps-Universität Marburg, Marburg, Germany.
  • Alexander N; Center for Mind, Brain and Behavior (CMBB), Universities of Marburg and Gießen, Marburg, Germany.
  • Bechdolf A; Center for Mind, Brain and Behavior (CMBB), Universities of Marburg and Gießen, Marburg, Germany.
  • Bermpohl F; Translational Clinical Psychology, Department of Psychology, Philipps-University Marburg, Marburg, Germany.
  • Bröckel K; Department of Psychiatry and Psychotherapy, Philipps-Universität Marburg, Marburg, Germany.
  • Brosch K; Center for Mind, Brain and Behavior (CMBB), Universities of Marburg and Gießen, Marburg, Germany.
  • Correll CU; Department of Psychiatry, Psychotherapy and Psychosomatic Medicine, Vivantes Hospital Am Urban and Vivantes Hospital Im Friedrichshain, Berlin, Germany.
  • Evermann U; Department of Psychiatry and Psychotherapy, Charité - Universitätsmedizin, Campus Mitte, Berlin, Germany.
  • Falkenberg I; Department of Psychiatry and Neuroscience, Charité Universitätsmedizin Berlin, Berlin, Germany.
  • Fallgatter A; Department of Psychiatry and Psychotherapy, Faculty of Medicine, TUD Dresden University of Technology, Dresden, Germany.
  • Flinkenflügel K; Department of Psychiatry and Psychotherapy, Philipps-Universität Marburg, Marburg, Germany.
  • Grotegerd D; Center for Mind, Brain and Behavior (CMBB), Universities of Marburg and Gießen, Marburg, Germany.
  • Hahn T; Department of Psychiatry, Zucker Hillside Hospital, Northwell Health, Glen Oaks, NY, USA.
  • Hautzinger M; Institute of Behavioral Science, Feinstein Institutes for Medical Research, Manhasset, NY, USA.
  • Jansen A; Department of Psychiatry, Zucker Hillside Hospital, Northwell Health, Glen Oaks, NY, USA.
  • Juckel G; Department of Child and Adolescent Psychiatry, Charité Universitätsmedizin Berlin, Berlin, Germany.
  • Krug A; Department of Psychiatry and Molecular Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA.
  • Lambert M; Center for Psychiatric Neuroscience, Feinstein Institute for Medical Research, Manhasset, NY, USA.
  • Leicht G; Department of Psychiatry and Psychotherapy, Philipps-Universität Marburg, Marburg, Germany.
  • Leopold K; Center for Mind, Brain and Behavior (CMBB), Universities of Marburg and Gießen, Marburg, Germany.
  • Meinert S; Department of Psychiatry and Psychotherapy, Philipps-Universität Marburg, Marburg, Germany.
  • Mikolas P; Center for Mind, Brain and Behavior (CMBB), Universities of Marburg and Gießen, Marburg, Germany.
  • Mulert C; Department of Psychiatry and Psychotherapy, University of Tübingen, Germany; German Center for Mental Health (DZPG), partner site Tübingen, Germany.
  • Nenadic I; Institute for Translational Psychiatry, University of Münster, Münster, Germany.
  • Pfarr JK; Institute for Translational Psychiatry, University of Münster, Münster, Germany.
  • Reif A; Institute for Translational Psychiatry, University of Münster, Münster, Germany.
  • Ringwald K; Department of Psychology, Clinical Psychology and Psychotherapy, Eberhard Karls University, Tübingen, Germany.
  • Ritter P; Department of Psychiatry and Psychotherapy, Philipps-Universität Marburg, Marburg, Germany.
  • Stamm T; Center for Mind, Brain and Behavior (CMBB), Universities of Marburg and Gießen, Marburg, Germany.
  • Straube B; Core-Facility BrainImaging, Faculty of Medicine, Philipps-Universität Marburg, Marburg, Germany.
  • Teutenberg L; Department of Psychiatry, Ruhr University Bochum, Bochum, Germany.
  • Thiel K; Department of Psychiatry and Psychotherapy, University Hospital of Bonn, Bonn, Germany.
  • Usemann P; Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Winter A; Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Wroblewski A; Department of Psychiatry, Psychotherapy and Psychosomatic Medicine, Vivantes Hospital Am Urban and Vivantes Hospital Im Friedrichshain, Berlin, Germany.
  • Dannlowski U; Department of Psychiatry and Psychotherapy, Faculty of Medicine, TUD Dresden University of Technology, Dresden, Germany.
  • Bauer M; Institute for Translational Psychiatry, University of Münster, Münster, Germany.
  • Pfennig A; Institute for Translational Neuroscience, University of Münster, Münster, Germany.
  • Kircher T; Department of Psychiatry and Psychotherapy, Faculty of Medicine, TUD Dresden University of Technology, Dresden, Germany.
Psychol Med ; : 1-11, 2024 May 27.
Article en En | MEDLINE | ID: mdl-38801091
ABSTRACT

BACKGROUND:

Individuals at risk for bipolar disorder (BD) have a wide range of genetic and non-genetic risk factors, like a positive family history of BD or (sub)threshold affective symptoms. Yet, it is unclear whether these individuals at risk and those diagnosed with BD share similar gray matter brain alterations.

METHODS:

In 410 male and female participants aged 17-35 years, we compared gray matter volume (3T MRI) between individuals at risk for BD (as assessed using the EPIbipolar scale; n = 208), patients with a DSM-IV-TR diagnosis of BD (n = 87), and healthy controls (n = 115) using voxel-based morphometry in SPM12/CAT12. We applied conjunction analyses to identify similarities in gray matter volume alterations in individuals at risk and BD patients, relative to healthy controls. We also performed exploratory whole-brain analyses to identify differences in gray matter volume among groups. ComBat was used to harmonize imaging data from seven sites.

RESULTS:

Both individuals at risk and BD patients showed larger volumes in the right putamen than healthy controls. Furthermore, individuals at risk had smaller volumes in the right inferior occipital gyrus, and BD patients had larger volumes in the left precuneus, compared to healthy controls. These findings were independent of course of illness (number of lifetime manic and depressive episodes, number of hospitalizations), comorbid diagnoses (major depressive disorder, attention-deficit hyperactivity disorder, anxiety disorder, eating disorder), familial risk, current disease severity (global functioning, remission status), and current medication intake.

CONCLUSIONS:

Our findings indicate that alterations in the right putamen might constitute a vulnerability marker for BD.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Psychol Med Año: 2024 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Psychol Med Año: 2024 Tipo del documento: Article País de afiliación: Alemania